Correlation Between Cytokinetics and Immunocore Holdings
Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytokinetics and Immunocore Holdings, you can compare the effects of market volatilities on Cytokinetics and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Immunocore Holdings.
Diversification Opportunities for Cytokinetics and Immunocore Holdings
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cytokinetics and Immunocore is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Cytokinetics i.e., Cytokinetics and Immunocore Holdings go up and down completely randomly.
Pair Corralation between Cytokinetics and Immunocore Holdings
Given the investment horizon of 90 days Cytokinetics is expected to generate 1.95 times more return on investment than Immunocore Holdings. However, Cytokinetics is 1.95 times more volatile than Immunocore Holdings. It trades about 0.03 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.03 per unit of risk. If you would invest 3,363 in Cytokinetics on December 12, 2024 and sell it today you would earn a total of 1,077 from holding Cytokinetics or generate 32.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Cytokinetics vs. Immunocore Holdings
Performance |
| Timeline |
| Cytokinetics |
| Immunocore Holdings |
Cytokinetics and Immunocore Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytokinetics and Immunocore Holdings
The main advantage of trading using opposite Cytokinetics and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.| Cytokinetics vs. Edgewise Therapeutics | ||
| Cytokinetics vs. Dyne Therapeutics | ||
| Cytokinetics vs. Stoke Therapeutics | ||
| Cytokinetics vs. Pliant Therapeutics |
| Immunocore Holdings vs. Arcellx | ||
| Immunocore Holdings vs. Ventyx Biosciences | ||
| Immunocore Holdings vs. Vaxcyte | ||
| Immunocore Holdings vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |